Advertisement
News
Advertisement

EnVivo readying Alzheimer’s data

Tue, 05/08/2012 - 11:33pm
Mass High Tech: The Journal of New England Technology

EnVivo Pharmaceuticals Inc. of Watertown, which focuses on central nervous system therapies, said it is analyzing data from the Phase 2b clinical trial of its EVP-6124 Alzheimer’s oral drug candidate and plans to release results at the upcoming Alzheimer’s Association International Conference in July in Vancouver.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading